The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACCELERATE DIAGNOSTICS INC | COM | 00430H102 | 31,266 | 2,175,795 | SH | SOLE | 2,175,795 | 0 | 0 | ||
ACCURAY INC | COM | 004397105 | 551 | 95,300 | SH | SOLE | 95,300 | 0 | 0 | ||
ADVAXIS INC | COM | 007624208 | 321 | 35,600 | SH | SOLE | 35,600 | 0 | 0 | ||
BIOGEN INC | COM | 09062X103 | 260 | 1,000 | SH | SOLE | 1,000 | 0 | 0 | ||
BIOLASE INC | COM | 090911108 | 1,685 | 1,285,903 | SH | SOLE | 1,285,903 | 0 | 0 | ||
CABOT OIL & GAS CORP | COM | 127097103 | 477 | 21,000 | SH | SOLE | 21,000 | 0 | 0 | ||
CELGENE CORP | COM | 151020104 | 77,975 | 779,051 | SH | SOLE | 779,051 | 0 | 0 | ||
CELGENE CORP | RIGHT 12/31/2030 | 151020112 | 312 | 238,214 | SH | SOLE | 238,214 | 0 | 0 | ||
CERUS CORP | COM | 157085101 | 157 | 26,500 | SH | SOLE | 26,500 | 0 | 0 | ||
COHERUS BIOSCIENCES INC | COM | 19249H103 | 159 | 7,500 | SH | SOLE | 7,500 | 0 | 0 | ||
COLLEGIUM PHARMACEUTICAL INC | COM | 19459J104 | 1,393 | 76,768 | SH | SOLE | 76,768 | 0 | 0 | ||
CONTRAFECT CORP | COM | 212326102 | 1,615 | 475,082 | SH | SOLE | 475,082 | 0 | 0 | ||
CORCEPT THERAPEUTICS INC | COM | 218352102 | 374 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | ||
ENCANA CORP | COM | 292505104 | 806 | 132,300 | SH | SOLE | 132,300 | 0 | 0 | ||
EQT CORP | COM | 26884L109 | 2,845 | 42,300 | SH | SOLE | 42,300 | 0 | 0 | ||
GENOCEA BIOSCIENCES INC | COM | 372427104 | 302 | 39,000 | SH | SOLE | 39,000 | 0 | 0 | ||
HANSEN MEDICAL INC | COM | 411307101 | 1,378 | 528,142 | SH | SOLE | 528,142 | 0 | 0 | ||
INTERCEPT PHARMACEUTICALS INC | COM | 45845P108 | 167 | 1,300 | SH | SOLE | 1,300 | 0 | 0 | ||
KURA ONCOLOGY INC | COM | 50127T109 | 320 | 79,114 | SH | SOLE | 79,114 | 0 | 0 | ||
MASIMO CORP | COM | 574795100 | 1,531 | 36,600 | SH | SOLE | 36,600 | 0 | 0 | ||
MEDIVATION INC | COM | 58501N101 | 863 | 18,760 | SH | SOLE | 18,760 | 0 | 0 | ||
MERCK & CO INC | COM | 58933Y105 | 794 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | ||
MERRIMACK PHARMACEUTICALS INC | COM | 590328100 | 368 | 44,000 | SH | SOLE | 44,000 | 0 | 0 | ||
METABOLIX INC RESTRICTED | COM | 591018809 | 3,870 | 2,263,166 | SH | SOLE | 2,263,166 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 997 | 25,200 | SH | SOLE | 25,200 | 0 | 0 | ||
NXSTAGE MEDICAL INC | COM | 67072V103 | 423 | 28,200 | SH | SOLE | 28,200 | 0 | 0 | ||
ONCOMED PHARMACEUTICALS INC | COM | 68234X102 | 715 | 70,689 | SH | SOLE | 70,689 | 0 | 0 | ||
OXFORD IMMUNOTEC GLOBAL PLC | COM | G6855A103 | 558 | 56,303 | SH | SOLE | 56,303 | 0 | 0 | ||
PACIFIC BIOSCIENCES OF CALIFORNIA INC | COM | 69404D108 | 230 | 27,000 | SH | SOLE | 27,000 | 0 | 0 | ||
PIONEER NATURAL RESOURCES CO (PXD) | COM | 723787107 | 422 | 3,000 | SH | SOLE | 3,000 | 0 | 0 | ||
QUIDEL CORP | COM | 74838J101 | 673 | 38,975 | SH | SOLE | 38,975 | 0 | 0 | ||
QUOTIENT LTD | COM | G73268107 | 512 | 58,200 | SH | SOLE | 58,200 | 0 | 0 | ||
RAPTOR PHARMACEUTICAL CORP | COM | 75382F106 | 184 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
ROKA BIOSCIENCE INC | COM | 775431109 | 174 | 252,307 | SH | SOLE | 252,307 | 0 | 0 | ||
SIENTRA INC | COM | 82621J105 | 433 | 63,300 | SH | SOLE | 63,300 | 0 | 0 | ||
TESARO INC | COM | 881569107 | 306 | 6,950 | SH | SOLE | 6,950 | 0 | 0 | ||
TRANSITION THERAPEUTICS INC | COM | 893716209 | 187 | 145,746 | SH | SOLE | 145,746 | 0 | 0 | ||
VERMILLION INC | COM | 92407M206 | 3,995 | 2,717,514 | SH | SOLE | 2,717,514 | 0 | 0 | ||
WRIGHT MEDICAL GROUP NV | COM | 98235T107 | 498 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
XENCOR INC | COM | 98401F105 | 165 | 12,300 | SH | SOLE | 12,300 | 0 | 0 |